Seeking Alpha

Genzyme, a Sanofi (SNY) company, and Isis Pharmaceuticals (ISIS) announce that the FDA has voted...

Genzyme, a Sanofi (SNY) company, and Isis Pharmaceuticals (ISIS) announce that the FDA has voted 9 to 6 to support the marketing of Kynamro, or mipomersen sodium, for the treatment of patients with Homozygous Familial Hypercholesterolemia. Isis +15% AH.
Comments (2)
  • Cerberus
    , contributor
    Comments (200) | Send Message
     
    Homo...Family....chole... what is this guy talking about?
    18 Oct 2012, 08:38 PM Reply Like
  • DavidHart
    , contributor
    Comments (37) | Send Message
     
    Genetically inherited gene that causes high cholesterol
    19 Oct 2012, 01:35 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector